End-point definition and trial design to advance tuberculosis vaccine development (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1183/16000617.0044-2022
Publication URI: http://dx.doi.org/10.1183/16000617.0044-2022
Type: Journal Article/Review
Parent Publication: European Respiratory Review
Issue: 164
ISSN: 0905-9180